PEDIATRICS Vol. 103 No. 1 January 1999, pp. 25-30
An Evaluation of the Safety and Immunogenicity of a Five-Component Acellular Pertussis, Diphtheria, and Tetanus Toxoid Vaccine (DTaP) When Combined With a Haemophilus influenzae Type b-Tetanus Toxoid Conjugate Vaccine (PRP-T) in Taiwanese Infants
Received Nov 7, 1997; accepted Jul 23, 1998.
,
,,
From the * National Taiwan University, Taipei, Taiwan;
Pasteur Mérieux Connaught, Toronto, Ontario, Canada;
§ Rhone Poulenc Taiwan, Taipei, Taiwan; Pasteur Mérieux
Connaught, Lyon, France; and ¶ University of Toronto, Toronto, Ontario,
Canada.
Objective. Immunologic interference particular to the Haemophilus influenzae type b (Hib) response has been observed with previous acellular pertussis-Hib combination vaccines. To test this hypothesis a clinical trial to assess the safety and immunogenicity of a five-component (pertussis toxoid [PT], filamentous hemagglutinin [FHA], pertactin [PRN], and fimbriae 2 and 3 [FIM]), pertussis vaccine combined with diphtheria and tetanus toxoids (DTaP) when given simultaneously with a lyophilized Hib-tetanus toxoid conjugate vaccine (PRP-T) in infants at 2, 4, 6, and 18 months of age was conducted. The study compared two methods of administration: both vaccines combined in a single syringe and administered as a single injection, or both vaccines administered concurrently but at separate sites of injection.
Methods. Healthy 2-month-old infants were enrolled at the National Taiwan University Hospital. DTaP, PRP-T, and oral poliomyelitis vaccine (OPV) were given at 2, 4, 6, and 18 months. Reaction information was collected by telephone 2 days after each vaccination. Serum was collected at 2, 6, 7, 18, and 19 months of age.
Results. One hundred thirty-five healthy infants were
enrolled in Taiwan, of which 127 (94%) completed the 18-month booster:
68 received the combined vaccine and 67 the separate vaccines. All
vaccines were well tolerated. No differences in rates of local and
systemic reactions were seen between the two methods of administration. No serious adverse events were reported. Serologic responses were comparable between the groups. Pertussis responses (enzyme-liked immunoabsorbant assay units [EU]/mL) at 7 months were, for combined versus separate, PT (131 vs 105), FHA (116 vs 116), PRN (100 vs 77),
and FIM (922 vs 702). At 19 months, pertussis results were, for
combined versus separate, PT (216 vs 182), FHA (203 vs 200), PRN (263 vs 197), and FIM (892 vs 732). Only the 7-month PT response in the
combined group was significantly higher (combined 131 EU/mL vs separate
105 EU/mL). After the third dose (age 6 months), all subjects
achieved serologic serum antibody levels indicative of protection
against Hib, diphtheria, tetanus, and poliovirus types 1, 2, and 3. In
fact, 96% of children had anti-PRP levels indicative of protection
(
0.15 µg/mL) against Hib after only two doses. At 7 months,
anti-PRP geometric mean titer values were 11.8 µg/mL in the combined
group compared with 13.0 µg/mL in the separate group. The anti-PRP
geometric mean titers after the 18-month booster were 58.5 µg/mL in
the combined group versus 55.3 µg/mL in the separate group.
Conclusion. The five-component DTaP vaccine may be combined with PRP-T vaccine without clinically significant immunologic interaction when given in a 2-, 4-, 6-, and 18-month schedule. Key words: acellular, whole cell, pertussis, whooping cough, vaccine, Haemophilus influenzae type b, clinical trial, interaction.
CiteULike 
Connotea 
Del.icio.us 
Digg 
Facebook 
Reddit 
Technorati 
Twitter What's this?
This article has been cited by other articles:
|
|
 |
|
  F. A. Guerra, M. M. Blatter, D. P. Greenberg, M. Pichichero, F. R. Noriega, and on behalf of the Pentacel Study Group Safety and Immunogenicity of a Pentavalent Vaccine Compared With Separate Administration of Licensed Equivalent Vaccines in US Infants and Toddlers and Persistence of Antibodies Before a Preschool Booster Dose: A Randomized, Clinical Trial Pediatrics, January 1, 2009; 123(1): 301 - 312. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N R E Kitchin, J Southern, R Morris, F Hemme, S Thomas, M W Watson, K Cartwright, and E Miller Evaluation of a diphtheria-tetanus-acellular pertussis-inactivated poliovirus-Haemophilus influenzae type b vaccine given concurrently with meningococcal group C conjugate vaccine at 2, 3 and 4 months of age Arch. Dis. Child., January 1, 2007; 92(1): 11 - 16. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M H Slack, S Cade, D Schapira, R J Thwaites, A Crowley-Luke, J Southern, R Borrow, and E Miller DT5aP-Hib-IPV and MCC vaccines: preterm infants' response to accelerated immunisation Arch. Dis. Child., April 1, 2005; 90(4): 338 - 341. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. J. Creusot, L. L. Thomsen, J. P. Tite, and B. M. Chain Local Cooperation Dominates Over Competition Between CD4+ T Cells of Different Antigen/MHC Specificity J. Immunol., July 1, 2003; 171(1): 240 - 246. [Abstract] [Full Text] [PDF]
|
|
